Robert B. Kargbo

1.8k total citations
34 papers, 801 citations indexed

About

Robert B. Kargbo is a scholar working on Organic Chemistry, Clinical Psychology and Molecular Biology. According to data from OpenAlex, Robert B. Kargbo has authored 34 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 12 papers in Clinical Psychology and 7 papers in Molecular Biology. Recurrent topics in Robert B. Kargbo's work include Psychedelics and Drug Studies (12 papers), Chemical synthesis and alkaloids (10 papers) and Alkaloids: synthesis and pharmacology (6 papers). Robert B. Kargbo is often cited by papers focused on Psychedelics and Drug Studies (12 papers), Chemical synthesis and alkaloids (10 papers) and Alkaloids: synthesis and pharmacology (6 papers). Robert B. Kargbo collaborates with scholars based in United States, United Kingdom and Spain. Robert B. Kargbo's co-authors include Gregory R. Cook, Stefan Kraft, Alexander M. Sherwood, Bikash C. Maity, Guy C. Lloyd‐Jones, Ian Shepperson, Yōko Takahashi, Santosh Bhor, Dirk Hoffmeister and Poncho Meisenheimer and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and The Journal of Organic Chemistry.

In The Last Decade

Robert B. Kargbo

30 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert B. Kargbo United States	15	591	259	195	192	59	34	801
Ignacio Carrera Uruguay	16	403 0.7×	243 0.9×	101 0.5×	106 0.6×	67 1.1×	41	642
Oleg S. Eltsov Russia	17	671 1.1×	175 0.7×	95 0.5×	50 0.3×	195 3.3×	147	1.0k
Gyula Simig Hungary	16	722 1.2×	292 1.1×	11 0.1×	97 0.5×	35 0.6×	129	943
Kurt Königsberger Austria	11	430 0.7×	247 1.0×	25 0.1×	60 0.3×	64 1.1×	20	603
James B. C. Mack United States	10	347 0.6×	67 0.3×	58 0.3×	117 0.6×	193 3.3×	12	624
Silvia Bartolucci Italy	11	280 0.5×	142 0.5×	12 0.1×	94 0.5×	14 0.2×	18	374
Miguel A. Toledo Spain	16	531 0.9×	327 1.3×	9 0.0×	150 0.8×	51 0.9×	30	864
Eric D. Moher United States	16	616 1.0×	351 1.4×	10 0.1×	51 0.3×	161 2.7×	28	860
A.R. Chadeayne United States	11	217 0.4×	88 0.3×	202 1.0×	23 0.1×	30 0.5×	35	330

Countries citing papers authored by Robert B. Kargbo

Since Specialization

Citations

This map shows the geographic impact of Robert B. Kargbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Kargbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Kargbo more than expected).

Fields of papers citing papers by Robert B. Kargbo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Kargbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Kargbo. The network helps show where Robert B. Kargbo may publish in the future.

Co-authorship network of co-authors of Robert B. Kargbo

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Kargbo. A scholar is included among the top collaborators of Robert B. Kargbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Kargbo. Robert B. Kargbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown, Rodney D., et al.. (2025). Synthesis of Psilocin, Psilocybin and 5‐MeO‐DMT Succinate, All Labelled With Carbon‐14 at the Indole 2‐Position. Journal of Labelled Compounds and Radiopharmaceuticals. 68(9-10). e4155–e4155.

Kargbo, Robert B.. (2023). Microbiome: The Next Frontier in Psychedelic Renaissance. SHILAP Revista de lepidopterología. 13(3). 386–401. 3 indexed citations

Steven, Alan, Carlos Mateos, Christopher C. Nawrat, et al.. (2023). Some Items of Interest to Process R&D Chemists and Engineers. Organic Process Research & Development. 27(5). 811–821. 1 indexed citations

Steven, Alan, Robert B. Kargbo, Carlos Mateos, et al.. (2023). Some Items of Interest to Process R&D Chemists and Engineers. Organic Process Research & Development. 27(1). 1–9.

Kargbo, Robert B.. (2023). Pioneering Changes in Psychiatry: Biomarkers, Psychedelics, and AI. ACS Medicinal Chemistry Letters. 14(9). 1134–1137. 2 indexed citations

Kargbo, Robert B., et al.. (2022). Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD). ACS Omega. 7(6). 5429–5436. 5 indexed citations

Fricke, Janis, Alexander M. Sherwood, Adam L. Halberstadt, Robert B. Kargbo, & Dirk Hoffmeister. (2021). Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity. Journal of Natural Products. 84(4). 1403–1408. 12 indexed citations

Kargbo, Robert B., et al.. (2020). An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin. Synthesis. 52(5). 688–694. 19 indexed citations

Fricke, Janis, Robert B. Kargbo, Lars Regestein, et al.. (2020). Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin. Chemistry - A European Journal. 26(37). 8281–8285. 30 indexed citations

10.

Lenz, Claudius, Alexander M. Sherwood, Robert B. Kargbo, & Dirk Hoffmeister. (2020). Taking Different Roads: l‐Tryptophan as the Origin of Psilocybe Natural Products. ChemPlusChem. 86(1). 28–35. 26 indexed citations

11.

Kargbo, Robert B.. (2020). SMARCA2/4 PROTAC for Targeted Protein Degradation and Cancer Therapy. ACS Medicinal Chemistry Letters. 11(10). 1797–1798. 8 indexed citations

12.

Richardson, Paul, Alan Steven, Robert B. Kargbo, et al.. (2020). Some Items of Interest to Process R&D Chemists and Engineers. Organic Process Research & Development. 24(9). 1549–1557.

13.

Sherwood, Alexander M., Adam L. Halberstadt, Adam K. Klein, et al.. (2020). Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin. Journal of Natural Products. 83(2). 461–467. 55 indexed citations

14.

Kargbo, Robert B.. (2020). PROTAC Compounds Targeting α-Synuclein Protein for Treating Neurogenerative Disorders: Alzheimer’s and Parkinson’s Diseases. ACS Medicinal Chemistry Letters. 11(6). 1086–1087. 63 indexed citations

15.

Kargbo, Robert B.. (2019). Modulation of RNA Splicing for the Treatment of Cancer. ACS Medicinal Chemistry Letters. 11(1). 7–8. 1 indexed citations

16.

Richardson, Paul, Alan Steven, David P. Day, et al.. (2017). Some Items of Interest to Process R&D Chemists and Engineers. Organic Process Research & Development. 21(5). 675–688. 1 indexed citations

17.

Kargbo, Robert B., et al.. (2012). ChemInform Abstract: Efficient One‐Pot Synthesis of 2‐Substituted Benzimidazoles from Triacyloxyborane Intermediates.. ChemInform. 43(20). 1 indexed citations

18.

Cook, Gregory R., Robert B. Kargbo, & Bikash C. Maity. (2005). Catalytic Enantioselective Indium-Mediated Allylation of Hydrazones. Organic Letters. 7(13). 2767–2770. 46 indexed citations

19.

Kargbo, Robert B.. (2004). Synthetic Applications of Tris(pentafluorophenyl)borane. Synlett. 1118–1119. 3 indexed citations

20.

Cook, Gregory R., Bikash C. Maity, & Robert B. Kargbo. (2004). Highly Diastereoselective Indium-Mediated Allylation of Chiral Hydrazones. Organic Letters. 6(11). 1741–1743. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact